Material
Peptide blend
Metabolic research
BPC-157 + GHK-Cu + TB-500 + KPV80 MG
A specialty blend format for laboratory studies involving metabolic and body-composition models.
MaterialPeptide blend
SpecificationPurity 99%+
Research contextComposite peptide research.
Veyvanta / profile
Compound profile
* Vial labels may use shortened names to keep the label legible. The full material and composition are stated in this profile.
Composition
BPC-157 10 MG + GHK-Cu 50 MG + TB-500 10 MG + KPV 10 MG.
Research context
Composite peptide research.
Research interest
Why it draws attention
KLOW combines four component-level research themes spanning BPC-157, copper-peptide biology, thymosin-related remodeling, and KPV inflammatory signaling.
Signals researchers are following
- 01
Tissue, extracellular-matrix, and inflammatory models
- 02
Copper-peptide, thymosin-related, and KPV signaling
Evidence levelComponent-level evidence
Published evidence / research profile
What the published research shows
A source-led view of the findings reported to date, the maturity of the evidence, and the limits that matter when interpreting it.
Evidence levelComponent-level evidence
Common research directions
- Tissue, extracellular-matrix, and inflammatory models
- Copper-peptide, thymosin-related, and KPV signaling
Reported findings
The individual components have separate preclinical literatures: BPC-157 in repair models, GHK-Cu in connective tissue, thymosin beta 4 in wound biology, and KPV in intestinal inflammation models. The KLOW blend itself has not been clinically studied.
How to read the evidence
Component findings cannot predict the combined blend. Thymosin beta 4 data are not direct evidence for TB-500, and KPV evidence is primarily cellular and animal.
Selected references
Pilot Human Safety Study of Intravenous BPC-157Altern Ther Health Med (2025)View sourceGHK Limits Metal-Induced Protein Aggregation and Cell StressMetallomics (2024)View sourceThymosin Beta 4 and Mitochondrial Transfer in Tissue GraftsFree Radic Biol Med (2025)View sourceBPC-157 and Rat Achilles Tendon HealingJ Orthop Res (2003)View sourceGHK-Cu and Connective Tissue in Experimental WoundsJ Clin Invest (1993)View sourceTopical Thymosin Beta 4 in Venous UlcersAnn N Y Acad Sci (2010)View sourceInflammation-Responsive KPV Delivery in Preclinical ModelsSci Adv (2026)View sourceKPV Uptake and Intestinal InflammationGastroenterology (2008)View source
This summary describes published research on the named material or its components. It does not establish safety, efficacy, equivalence, or suitability of this Veyvanta research product for human use.
Lab math
Reconstitution & measurement calculator
Convert a declared vial amount and diluent volume into nominal concentration, liquid volume, and the equivalent position on a U-100 scale.
Research product
Research productBPC-157 + GHK-Cu + TB-500 + KPV / 80 MG
Component mode calculates against one declared ingredient. Total mode calculates against the full declared blend mass.
Calculated measurement
Enter a positive diluent volume and target amount to calculate.
A calculation, not a protocol
This tool performs unit conversion only. It does not recommend an amount, frequency, route, diluent, handling method, or human use. Results assume ideal mixing and a U-100 scale of 100 units per mL; validated laboratory procedures and material-specific compatibility take priority.
Vial verification
Verify this vial
This is the evergreen product profile. Enter the code from a physical vial to display its specific record.
Verify this vial
Vial verification QR
This QR code opens the current product profile with its associated vial record.
Metabolic research
